Navigation Links
Endologix Announces FDA Approval of AFX™ Endovascular AAA System
Date:6/15/2011

IRVINE, Calif., June 15, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its next generation product, the AFX™ Endovascular AAA System, for the treatment of abdominal aortic aneurysms (AAA).  Endologix is introducing AFX at the Annual Meeting of the Society for Vascular Surgery (SVS), which is taking place June 16-18, 2011 in Chicago, IL.  

AFX builds upon Endologix's clinically proven anatomical fixation technology with  a new low profile, highly precise delivery system and a state of the art, proprietary stent graft material (STRATA™).  The key features of the AFX System include:

  • Low profile 17Fr introducer sheath – The entire family of AFX stent grafts, which range in diameter from 13 to 34 millimeters, are delivered through a low profile, hydrophilically-coated 17Fr  introducer sheath – obviating the need for exchanges. Notably, this sheath technology, combined with the System's percutaneous (9Fr) contralateral access, makes AFX the lowest profile device approved in the U.S. for the treatment of the most common AAAs – those with aortic neck diameters of 22 millimeters or larger.
  • Precise delivery and deployment – The AFX delivery system features an ergonomic dial mechanism that provides physicians with precise, controlled stent graft positioning and deployment.  These features were designed with significant input from endovascular specialists globally.  
  • STRATA expanded polytetrafluoroethylene (ePTFE) graft – AFX stent grafts are constructed using Endologix's proprietary new STRATA graft material. STRATA is a durable, highly conformable material featuring enhanced stent graft sealin
    '/>"/>

  • SOURCE Endologix, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Endologix Comments on Alleged Patent Infringement
    2. Endologix Responds to Alleged Patent Infringement
    3. Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
    4. Endologix Reports 47% Third Quarter 2009 Revenue Growth
    5. Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement
    6. Endologix Enters Development Agreement and Exclusive License for Balloon Expandable Stent Technology
    7. Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions
    8. Endologix to Report Third Quarter 2010 Financial Results on October 27, 2010
    9. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
    10. Endologix to Present at Oppenheimer 21st Annual Healthcare Conference
    11. Endologix Reports 30% Third Quarter 2010 Revenue Growth
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2014)... York , September 2, 2014 ... published by Transparency Market Research "Latin America Home ... Devices, Therapeutic Home Healthcare Devices, Mobility Assist Devices ... Telemedicine, Respiratory Therapy, Infusion Therapy and Unskilled Home ... Trends and Forecast, 2014 - 2020" the Latin ...
    (Date:9/2/2014)... Spanje, September 2, 2014 ... AF Registry bij het ESC CONGRESS 2014 ... patiënten met risico op beroerte in de ... Gegevens van bijna 12.500 patiënten ingeschreven in ... Fibrillation (GARFIELD-AF), een innovatief, onafhankelijk initiatief op ...
    (Date:9/2/2014)... 2, 2014 , ... provide insight into treatment and outcomes of patients ... --   Data from nearly 12,500 ... the FIELD-Atrial Fibrillation (GARFIELD-AF), an innovative, independent academic ... for atrial fibrillation (AF) patients remain sub-optimal despite ...
    Breaking Medicine Technology:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 2Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 3Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 4Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 5Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 6Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 7Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 8Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 9Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 10Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 3Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 4Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 5Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 6Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 7Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 8Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 9
    ... Inc. (Nasdaq: REGN ) will webcast its ... 15, 2011.  The presentation is scheduled for 2:10 p.m. ... Company,s web site, www.regeneron.com , on the Investor ... be available after the live webcast through March 17, ...
    ... Pervasis Therapeutics announced today that the U.S. Food and ... for Vascugel® for the prevention of hemodialysis access failure ... Vascugel, a novel endothelial cell-based therapy and Pervasis, ... response following surgical interventions to create vascular access points ...
    Cached Medicine Technology:Pervasis Receives FDA Fast Track Status for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis 2Pervasis Receives FDA Fast Track Status for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis 3Pervasis Receives FDA Fast Track Status for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis 4Pervasis Receives FDA Fast Track Status for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis 5
    (Date:9/2/2014)... 02, 2014 Becker's Healthcare is ... Educational Program on October 23-25, 2014 at the ... Meeting - The Business and Operations of ASCs ... high-quality continuing education, networking events, and an exhibit ... , Outstanding educational offerings throughout the three-day event, ...
    (Date:9/2/2014)... Today, Therapy Changes released ... Me?” The guide outlines common questions an individual may ... to common types of groups an individual can attend. ... the interventions of the therapist, but also from observing ... members,” says Rochelle Perper, Ph.D. and founder of Therapy ...
    (Date:9/2/2014)... Washington, DC (PRWEB) September 02, 2014 TCG, ... named by Inc. 5000 as one of the fastest-growing companies ... the eighth time total. TCG was previously recognized in 2013, ... 2001. , TCG’s revenue has grown 86% from 2010 to ... of the fastest growing businesses in America - up 635 ...
    (Date:9/2/2014)... Columbia, SC (PRWEB) September 02, 2014 The ... an outreach fair and public town hall meeting for Veterans ... be available at the outreach fair to provide Veterans with ... B. McMurry. “The town hall will provide a forum where ... our VA programs.” , The outreach fair will be held ...
    (Date:9/2/2014)... in California, the percentage undergoing a double mastectomy increased ... not associated with a lower risk of death than ... the September 3 issue of JAMA . The ... one breast was associated with a higher risk of ... , Randomized trials have demonstrated similar survival for patients ...
    Breaking Medicine News(10 mins):Health News:Becker's Healthcare Announces Ambulatory Surgery Center Educational Program 2Health News:Becker's Healthcare Announces Ambulatory Surgery Center Educational Program 3Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Increase seen in use of double mastectomy 2Health News:Increase seen in use of double mastectomy 3
    ... , , LAS VEGAS, Aug. ... America (HCA), dozens of registered nurses from HCA facilities across the ... of nurses from the company,s MountainView Hospital, after management refused to ... Nurses Organizing Committee (CNA/NNOC). , , MountainView ...
    ... , , , ... The Simmons firm, a leading national law firm in the fight ... one of the foremost trial attorneys in the country, has joined ... has tried dozens of asbestos cancer cases since the late 1970s. ...
    ... uncovers big jump between 1999-2006, especially among older females ... involving more than 6,000 American women suggests that blood ... big rise noted over the past decade. , Using ... Prevention,s National Health and Nutrition Examination Survey (NHANES), a ...
    ... , , FARMINGTON HILLS, Mich., ... (DCC) with a group purchasing contract to provide RFID Asset ... alliance is the largest in the country, comprised of more ... over $31 billion in annual purchasing power. , ...
    ... VERONA, N.Y., Aug. 24 , , , WHAT: ... Atunyote Golf Club course in Verona, N.Y., today in a skins, ... Foundation., ... top-ranked golfer, Tiger Woods. Looking to fend off Woods will, ...
    ... , , ATLANTA, Aug. 24 ... the nation,s largest direct retailer of foot and lower body ... 20th Anniversary. Since 1989, the company has upheld two consumer ... comfort, and providing expert customer information and service. FootSmart offers ...
    Cached Medicine News:Health News:Nurses from HCA Hospitals Nationwide Rally in Support of MountainView RNs Today 2Health News:Decorated Trial Attorney Conard Metcalf Joins Simmons Firm as 'Of Counsel' 2Health News:Decorated Trial Attorney Conard Metcalf Joins Simmons Firm as 'Of Counsel' 3Health News:Blood Mercury Levels Rising Among U.S. Women 2Health News:Tiger Woods, Camilo Villegas, Mike Weir and Notah Begay III Play at 2009 Notah Begay III Foundation Challenge Monday, August 24 2Health News:Benchmark Brands Celebrates 20th Anniversary 2
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: